These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17713021)

  • 21. Interleukin-2: Old and New Approaches to Enhance Immune-Therapeutic Efficacy.
    Dhupkar P; Gordon N
    Adv Exp Med Biol; 2017; 995():33-51. PubMed ID: 28321811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8
    Hasan AN; Selvakumar A; Shabrova E; Liu XR; Afridi F; Heller G; Riviere I; Sadelain M; Dupont B; O'Reilly RJ
    Clin Exp Immunol; 2016 Nov; 186(2):249-265. PubMed ID: 27227483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-7 in HIV pathogenesis and therapy.
    Chahroudi A; Silvestri G
    Eur Cytokine Netw; 2010 Sep; 21(3):202-7. PubMed ID: 20729180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune impairment in patients with terminal cancers: influence of cancer treatments and cytomegalovirus infection.
    Chen IH; Lai YL; Wu CL; Chang YF; Chu CC; Tsai IF; Sun FJ; Lu YT
    Cancer Immunol Immunother; 2010 Feb; 59(2):323-34. PubMed ID: 19685052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of common gamma-chain cytokines, interleukin-2, interleukin-7, and interleukin-15 for the in vitro generation of human tumor-reactive T lymphocytes for adoptive cell transfer therapy.
    Liu S; Riley J; Rosenberg S; Parkhurst M
    J Immunother; 2006; 29(3):284-93. PubMed ID: 16699371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.
    Shindo Y; Fuchs AG; Davis CG; Eitas T; Unsinger J; Burnham CD; Green JM; Morre M; Bochicchio GV; Hotchkiss RS
    J Leukoc Biol; 2017 Feb; 101(2):543-554. PubMed ID: 27630218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells.
    Seddon B; Tomlinson P; Zamoyska R
    Nat Immunol; 2003 Jul; 4(7):680-6. PubMed ID: 12808452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.
    Capitini CM; Chisti AA; Mackall CL
    J Intern Med; 2009 Aug; 266(2):141-53. PubMed ID: 19623690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In this issue: Role of immune cells, immune modulating factors and immunotoxins in cancer immunotherapy.
    Kumar H; Bot A
    Int Rev Immunol; 2017 Jul; 36(4):205-206. PubMed ID: 28537793
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunotherapy of cancer: from vision to standard clinical practice.
    Huber CH; Wölfel T
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):367-74. PubMed ID: 15067541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Universal and stemness-related tumor antigens: potential use in cancer immunotherapy.
    Parmiani G; Russo V; Marrari A; Cutolo G; Casati C; Pilla L; Maccalli C; Rivoltini L; Castelli C
    Clin Cancer Res; 2007 Oct; 13(19):5675-9. PubMed ID: 17908956
    [No Abstract]   [Full Text] [Related]  

  • 34. Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer.
    Bizzini B; Drouet B; Zagury D; Abitbol M; Burny A; Boissier MC
    Immunotherapy; 2010 May; 2(3):347-65. PubMed ID: 20635900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune enhancement and anti-tumour activity of IL-23.
    Hao JS; Shan BE
    Cancer Immunol Immunother; 2006 Nov; 55(11):1426-31. PubMed ID: 16676182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy as an Option for Cancer Treatment.
    Rusch T; Bayry J; Werner J; Shevchenko I; Bazhin AV
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):89-96. PubMed ID: 29026920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design.
    Waldmann TA
    Nat Rev Immunol; 2006 Aug; 6(8):595-601. PubMed ID: 16868550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological Response Modifier in Cancer Immunotherapy.
    Liu R; Luo F; Liu X; Wang L; Yang J; Deng Y; Huang E; Qian J; Lu Z; Jiang X; Zhang D; Chu Y
    Adv Exp Med Biol; 2016; 909():69-138. PubMed ID: 27240457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-2, IL-7, and IL-15: Multistage regulators of CD4(+) T helper cell differentiation.
    Read KA; Powell MD; McDonald PW; Oestreich KJ
    Exp Hematol; 2016 Sep; 44(9):799-808. PubMed ID: 27423815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent Antitumor T-Cell Memory Is Generated by Curative Viral Oncolytic Immunotherapy But Not Curative Chemotherapy.
    Gao Y; Bergman I
    Anticancer Res; 2018 Dec; 38(12):6621-6629. PubMed ID: 30504370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.